US5795737A
(en)
*
|
1994-09-19 |
1998-08-18 |
The General Hospital Corporation |
High level expression of proteins
|
US5777079A
(en)
*
|
1994-11-10 |
1998-07-07 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
US5625048A
(en)
*
|
1994-11-10 |
1997-04-29 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
DE69618350T2
(de)
*
|
1995-01-31 |
2002-09-19 |
Bioimage As Soeborg |
Ein verfahren zum nachweis biologisch aktiver substanzen
|
DK1143011T3
(da)
*
|
1995-01-31 |
2006-03-20 |
Bioimage As |
Fremgangsmåde til påvisning af biologisk aktive substanser
|
US5958713A
(en)
*
|
1995-01-31 |
1999-09-28 |
Novo Nordisk A/S |
Method of detecting biologically active substances by using green fluorescent protein
|
GB9504446D0
(en)
*
|
1995-03-06 |
1995-04-26 |
Medical Res Council |
Improvements in or relating to gene expression
|
ATE184613T1
(de)
*
|
1995-09-22 |
1999-10-15 |
Novo Nordisk As |
Varianten des grünen fluoreszenzproteins, gfp
|
US6455300B1
(en)
|
1995-12-08 |
2002-09-24 |
Han Htun |
Method and compositions for monitoring DNA binding molecules in living cells
|
US5874304A
(en)
*
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
US6803188B1
(en)
|
1996-01-31 |
2004-10-12 |
The Regents Of The University Of California |
Tandem fluorescent protein constructs
|
US6900304B2
(en)
|
1996-01-31 |
2005-05-31 |
The Regents Of The University Of California |
Emission ratiometric indicators of phosphorylation
|
US6077697A
(en)
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
JP2000509274A
(ja)
*
|
1996-04-19 |
2000-07-25 |
マイコーゲン プラント サイエンス インク. |
インビボマーカーを有するトランスジェニック植物のモニタリング
|
AR006928A1
(es)
|
1996-05-01 |
1999-09-29 |
Pioneer Hi Bred Int |
Una molecula de adn aislada que codifica una proteina fluorescente verde como marcador rastreable para la transformacion de plantas, un metodo para laproduccion de plantas transgenicas, un vector de expresion, una planta transgenica y celulas de dichas plantas.
|
US6096865A
(en)
*
|
1996-05-06 |
2000-08-01 |
Amgen Inc. |
Mutants of the green fluorescent protein having improved fluorescent properties at 37°
|
US6027881A
(en)
*
|
1996-05-08 |
2000-02-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
|
US5989835A
(en)
|
1997-02-27 |
1999-11-23 |
Cellomics, Inc. |
System for cell-based screening
|
US5876711A
(en)
*
|
1996-05-31 |
1999-03-02 |
Onyx Pharmaceuticals, Inc. |
Methods and compositions for determining the tumor suppressor status of cells
|
US5925558A
(en)
*
|
1996-07-16 |
1999-07-20 |
The Regents Of The University Of California |
Assays for protein kinases using fluorescent protein substrates
|
US5912137A
(en)
*
|
1996-07-16 |
1999-06-15 |
The Regents Of The University Of California |
Assays for protein kinases using fluorescent
|
US6593135B2
(en)
|
1996-08-16 |
2003-07-15 |
The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Long wavelength engineered fluorescent proteins
|
US6124128A
(en)
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
WO1998021355A1
(en)
|
1996-11-15 |
1998-05-22 |
Life Technologies, Inc. |
Mutants of green fluorescent protein
|
US6245564B1
(en)
*
|
1997-01-23 |
2001-06-12 |
Cornell Research Foundation, Inc. |
Method for separating cells
|
US7117098B1
(en)
|
1997-02-27 |
2006-10-03 |
Cellomics, Inc. |
Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm
|
US6727071B1
(en)
|
1997-02-27 |
2004-04-27 |
Cellomics, Inc. |
System for cell-based screening
|
CA2282658C
(en)
|
1997-02-27 |
2003-02-25 |
Cellomics, Inc. |
A system for cell-based screening
|
US5998204A
(en)
*
|
1997-03-14 |
1999-12-07 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
US6197928B1
(en)
|
1997-03-14 |
2001-03-06 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
GB9706414D0
(en)
*
|
1997-03-27 |
1997-05-14 |
Univ Manchester |
Detection of DNA damage
|
US6342345B1
(en)
|
1997-04-02 |
2002-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of molecular interactions by reporter subunit complementation
|
DE69824763T2
(de)
*
|
1997-04-07 |
2005-07-07 |
Bioimage A/S |
Verfahren zum Screenen von Substanzen die einen effekt auf intrazelluläre Translokation haben
|
US6046925A
(en)
*
|
1997-04-14 |
2000-04-04 |
The Regents Of The University Of California |
Photochromic fluorescent proteins and optical memory storage devices based on fluorescent proteins
|
DE19715683C2
(de)
*
|
1997-04-15 |
1999-11-11 |
Max Planck Gesellschaft |
Neue Reportervektoren für One-Hybrid und Two-Hybrid Systeme
|
AU9161998A
(en)
*
|
1997-07-29 |
1999-02-22 |
Unilever Plc |
Plasmids
|
GB2328209A
(en)
*
|
1997-08-16 |
1999-02-17 |
Stefan Andreas Oehler |
Vectors which express a coloured protein for detection of integration into a cell
|
WO1999037142A1
(en)
*
|
1998-01-27 |
1999-07-29 |
Novo Nordisk A/S |
Method for producing transgenic animals
|
SK287538B6
(sk)
|
1998-03-20 |
2011-01-04 |
Commonwealth Scientific And Industrial Research Organisation |
Syntetický gén obsahujúci dispergovanú alebo cudzorodú deoxyribonukleovú molekulu, génový konštrukt obsahujúci tento syntetický gén a prípravok obsahujúci tento syntetický gén
|
EP1925320A3
(de)
|
1998-03-27 |
2008-09-03 |
Prolume, Ltd. |
Luciferasen, fluoreszierende Proteine, Nukleinsäuren zur Kodierung der Luciferasen und der fluoreszierenden Proteine sowie deren Verwendung zur Diagnose, zum Screening mit hohem Durchsatz und zur Behandlung neuartiger Probleme
|
US7090976B2
(en)
|
1999-11-10 |
2006-08-15 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising Renilla GFP
|
JP2002527761A
(ja)
*
|
1998-10-15 |
2002-08-27 |
バイオイメージ エイ/エス |
細胞応答への影響に関する量的情報を入手するための改良方法
|
EP1031630B1
(de)
*
|
1999-02-22 |
2004-10-20 |
Matsushita Electric Industrial Co., Ltd. |
Verfahren zum Nachweis von Bakterien
|
US8148110B2
(en)
|
1999-03-15 |
2012-04-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of molecular interactions by β-lactamase reporter fragment complementation
|
WO2001009177A2
(en)
*
|
1999-07-29 |
2001-02-08 |
Whitehead Institute For Biomedical Research |
Affinity fluorescent proteins and uses thereof
|
US6716614B1
(en)
|
1999-09-02 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
DK1228233T3
(da)
*
|
1999-11-10 |
2007-05-14 |
Rigel Pharmaceuticals Inc |
Fremgangsmåder og sammensætninger omfattende grönfluorescerende proteiner (GFP) fra Renilla
|
WO2001042786A2
(en)
|
1999-12-09 |
2001-06-14 |
Cellomics, Inc. |
System for cell based screening : cell spreading
|
KR100414641B1
(ko)
*
|
2000-04-07 |
2004-01-13 |
동부한농화학 주식회사 |
형질전환식물체의 생체분석방법 및 그를 이용한 시스템
|
EP1299414B1
(de)
|
2000-06-19 |
2009-08-12 |
Fisher BioImage ApS |
Fluoreszierende proteine
|
KR100393709B1
(ko)
*
|
2000-08-07 |
2003-08-06 |
광주과학기술원 |
재조합 동물 세포주를 이용한 환경 오염 물질의 탐지 방법
|
EP1624062A3
(de)
*
|
2000-10-27 |
2006-02-22 |
Lexicon Genetics Incorporated |
Humane 7tm Proteine und dafür kodierende Polynukleotide
|
CA2427701A1
(en)
*
|
2000-10-30 |
2002-05-10 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding the same
|
DE10136702B4
(de)
|
2000-12-27 |
2004-04-22 |
Axiogenesis Ag |
System zur zell- und entwicklungsspezifischen Selektion differenzierender embryonaler Stammzellen, adulter Stammzellen und embryonaler Keimbahnzellen
|
EP1236738A1
(de)
*
|
2001-02-23 |
2002-09-04 |
Jungbauer, Alois, Professor Dr. |
Interner Standard für ein elektrophoretisches und chromatograpgisches Trennungs-Verfahren
|
JP3929250B2
(ja)
*
|
2001-03-08 |
2007-06-13 |
株式会社ルネサステクノロジ |
半導体装置
|
WO2002077011A2
(en)
|
2001-03-12 |
2002-10-03 |
The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Oxidation-reduction sensitive green fluorescent protein variants
|
US20020188965A1
(en)
|
2001-04-20 |
2002-12-12 |
Zou-Yu Zhao |
Methods of transforming plants
|
EP1401849A4
(de)
|
2001-05-30 |
2005-05-18 |
Chromos Molecular Systems Inc |
Künstliche pflanzenchromosomen, deren verwendung und verfahren zur herstellung von künstlichen pflanzenchromosomen
|
JP3829252B2
(ja)
*
|
2001-06-08 |
2006-10-04 |
独立行政法人理化学研究所 |
蛍光蛋白質
|
US6894205B2
(en)
*
|
2001-06-22 |
2005-05-17 |
Vanderbilt University |
Assay for toxin induced neuronal degeneration and viability in C. elegans
|
US7393656B2
(en)
|
2001-07-10 |
2008-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for risk stratification
|
US8048644B1
(en)
|
2001-08-01 |
2011-11-01 |
The University Of North Carolina At Charlotte |
Biological indicator for monitoring the transport of micro-organisms in the environment
|
US7150989B2
(en)
|
2001-08-10 |
2006-12-19 |
Cornell Research Foundation, Inc. |
Telomerase immortalized neural progenitor cells
|
CN1582332A
(zh)
*
|
2001-12-29 |
2005-02-16 |
Seoul大学校产学协力财团 |
转染gfp的克隆猪、敲除gt的克隆猪及其生产方法
|
AU2003210959A1
(en)
*
|
2002-02-12 |
2003-09-04 |
Cornell Research Foundation, Inc. |
Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
|
US9453251B2
(en)
|
2002-10-08 |
2016-09-27 |
Pfenex Inc. |
Expression of mammalian proteins in Pseudomonas fluorescens
|
DE10256083A1
(de)
*
|
2002-11-29 |
2004-08-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen
|
US7384744B2
(en)
*
|
2002-11-29 |
2008-06-10 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
|
JP4904153B2
(ja)
|
2003-06-20 |
2012-03-28 |
アキシオジェネシス エージー |
胚性幹(es)細胞系での組織モデリング
|
PT2308961T
(pt)
|
2003-08-25 |
2017-06-07 |
Monsanto Technology Llc |
Elementos reguladores de tubulina para usar em plantas
|
US8883147B2
(en)
|
2004-10-21 |
2014-11-11 |
Xencor, Inc. |
Immunoglobulins insertions, deletions, and substitutions
|
US8399618B2
(en)
|
2004-10-21 |
2013-03-19 |
Xencor, Inc. |
Immunoglobulin insertions, deletions, and substitutions
|
EP2361984A1
(de)
|
2003-10-09 |
2011-08-31 |
E. I. du Pont de Nemours and Company |
Genexpressionsunterdrückung mittels modifizierter mikro-RNA-Molekülen
|
US7279275B2
(en)
|
2003-11-03 |
2007-10-09 |
Washington University |
Methods and compositions for detection of segmented negative strand RNA viruses
|
WO2005069986A2
(en)
|
2004-01-20 |
2005-08-04 |
Monsanto Technology Llc |
Chimeric promoters for use in plants
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
EP1740945B1
(de)
|
2004-04-07 |
2018-09-19 |
Ncardia AG |
Nichtinvasive, in-vitro-funktionelle gewebetestsysteme
|
WO2005108598A1
(en)
|
2004-05-11 |
2005-11-17 |
Axiogenesis Ag |
Assay for drug discovery based on in vitro differentiated cells
|
KR20130019457A
(ko)
|
2004-07-26 |
2013-02-26 |
다우 글로벌 테크놀로지스 엘엘씨 |
균주 조작에 의한 개선된 단백질 발현 방법
|
AU2005270968A1
(en)
*
|
2004-08-04 |
2006-02-16 |
Merck Serono Sa |
Capsules containing transfected cells, method for preparing the same and uses thereof for immunization and vaccination
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
CN102746404B
(zh)
|
2004-11-12 |
2016-01-20 |
赞科股份有限公司 |
对FcRn的结合被改变的Fc变体
|
AU2006249144B2
(en)
|
2005-05-18 |
2011-11-17 |
Ablynx Nv |
Improved NanobodiesTM against Tumor Necrosis Factor-alpha
|
NZ563392A
(en)
|
2005-05-20 |
2009-12-24 |
Ablynx Nv |
Improved Nanobodies(TM) for the treatment of aggregation-mediated disorders
|
US8362250B2
(en)
|
2005-05-24 |
2013-01-29 |
Enzo Biochem, Inc. |
Fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest
|
EP3138403A1
(de)
|
2005-08-09 |
2017-03-08 |
Revivicor, Inc. |
Ctla4-ig exprimierende transgene huftiere und verwendungen davon
|
US8859846B2
(en)
|
2005-09-21 |
2014-10-14 |
E. I. Du Pont De Nemours And Company |
Doubling of chromosomes in haploid embryos
|
RU2412250C2
(ru)
|
2005-11-04 |
2011-02-20 |
Закрытое акционерное общество "ЕВРОГЕН" |
Модифицированные зеленые флуоресцентные белки и способы их использования
|
US8298818B2
(en)
|
2006-04-28 |
2012-10-30 |
University Of Florida Research Foundation, Inc. |
Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter
|
US7855326B2
(en)
|
2006-06-06 |
2010-12-21 |
Monsanto Technology Llc |
Methods for weed control using plants having dicamba-degrading enzymatic activity
|
CA2653742C
(en)
*
|
2006-06-06 |
2016-01-05 |
Monsanto Technology Llc |
Method for selection of plant cells transformed with a polynucleotide encoding dicamba monooxygenase using auxin-like herbicides
|
US20080004410A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Yu-Chin Lai |
Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
|
US20100003189A1
(en)
|
2006-07-14 |
2010-01-07 |
The Regents Of The University Of California |
Cancer biomarkers and methods of use thereof
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
CA2663811A1
(en)
|
2006-10-05 |
2008-04-17 |
E.I. Du Pont De Nemours And Company |
Maize microrna sequences
|
EP2514767A1
(de)
|
2006-12-19 |
2012-10-24 |
Ablynx N.V. |
Gegen Metalloproteinase der ADAM-Familie gerichtete Aminosäuren und Polypeptide damit zur Behandlung von Erkrankungen und Störungen im Zusammenhang mit ADAM
|
WO2008074839A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
US7838729B2
(en)
|
2007-02-26 |
2010-11-23 |
Monsanto Technology Llc |
Chloroplast transit peptides for efficient targeting of DMO and uses thereof
|
US9580719B2
(en)
|
2007-04-27 |
2017-02-28 |
Pfenex, Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
CN101688213A
(zh)
|
2007-04-27 |
2010-03-31 |
陶氏环球技术公司 |
用于快速筛选微生物宿主以鉴定某些在表达异源蛋白质方面具有改善的产量和/或质量的菌株的方法
|
CL2008002444A1
(es)
|
2007-08-21 |
2009-09-04 |
Amgen Inc |
Anticuerpo o fragmento del mismo que se une a la proteina c-fms humana; molecula de acido nucleico que la codifica; vector y celula huesped; metodo de elaboracion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir una condicion asociada con c-fms en un paciente.
|
EP2179037A4
(de)
|
2007-08-21 |
2010-12-22 |
Nodality Inc |
Diagnose-, prognose- und behandlungsverfahren
|
US20090081715A1
(en)
*
|
2007-09-07 |
2009-03-26 |
Cobalt Technologies, Inc., A Delaware Corporation |
Engineered Light-Emitting Reporter Genes
|
TW200918553A
(en)
|
2007-09-18 |
2009-05-01 |
Amgen Inc |
Human GM-CSF antigen binding proteins
|
SG10201606120XA
(en)
|
2007-10-02 |
2016-09-29 |
Theranos Inc |
Modular Point-Of-Care Devices And Uses Thereof
|
US8619257B2
(en)
|
2007-12-13 |
2013-12-31 |
Kimberley-Clark Worldwide, Inc. |
Recombinant bacteriophage for detection of nosocomial infection
|
SI2808343T1
(sl)
|
2007-12-26 |
2019-10-30 |
Xencor Inc |
Fc-variante s spremenjeno vezavo na FcRn
|
CN102056945A
(zh)
|
2008-04-07 |
2011-05-11 |
埃博灵克斯股份有限公司 |
针对Notch途径的单可变结构域
|
SI2262896T1
(sl)
|
2008-04-07 |
2014-05-30 |
Monsanto Technology Llc |
Rastlinski regulatorni elementi in njihove uporabe
|
CL2009000879A1
(es)
|
2008-04-09 |
2010-05-07 |
Talfryn S A |
Metodo para fabricar un producto en un biorreactor que comprende cultivar microorganismos que son adaptados o mutagenizados para que exhiban por lo menos un 150% de tolerancia al producto; sistema para fabricar un producto; biorreactor.
|
US9250249B2
(en)
|
2008-09-08 |
2016-02-02 |
Enzo Biochem, Inc. |
Autophagy and phospholipidosis pathway assays
|
US9334281B2
(en)
*
|
2008-09-08 |
2016-05-10 |
Enzo Life Sciences, Inc. |
Fluorochromes for organelle tracing and multi-color imaging
|
US8309306B2
(en)
|
2008-11-12 |
2012-11-13 |
Nodality, Inc. |
Detection composition
|
WO2010070145A2
(en)
|
2008-12-19 |
2010-06-24 |
Ablynx N.V. |
Method for generation of immunoglobulin sequences
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
US8242248B2
(en)
|
2009-03-23 |
2012-08-14 |
Nodality, Inc. |
Kits for multiparametric phospho analysis
|
NZ595461A
(en)
|
2009-04-10 |
2013-01-25 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
DK2438087T3
(en)
|
2009-06-05 |
2017-08-28 |
Ablynx Nv |
TRIVALENT NANOBODY CONSTRUCTIONS AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS (HRSV) FOR PREVENTION AND / OR TREATMENT OF AIR INFECTIONS
|
EP2446044A4
(de)
*
|
2009-06-26 |
2013-04-10 |
Cobalt Technologies Inc |
Integriertes system und verfahren zur herstellung von bioprodukten
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
US9644022B2
(en)
|
2009-11-30 |
2017-05-09 |
Ablynx N.V. |
Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
WO2011083140A1
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Immunoglobulin single variable domain directed against human cxcr4
|
BR122021001281B1
(pt)
|
2010-01-14 |
2022-03-03 |
Monsanto Technology Llc |
Molécula de dna compreendendo elementos reguladores de plantas
|
AU2011239689A1
(en)
|
2010-04-15 |
2012-11-08 |
Amgen Inc. |
Human FGF receptor and beta-Klotho binding proteins
|
EP3508854A1
(de)
|
2010-04-27 |
2019-07-10 |
The Regents of The University of California |
Krebsbiomarker und verfahren zur verwendung davon
|
CA2809643C
(en)
|
2010-08-30 |
2019-09-24 |
John P. Davies |
Sugarcane bacilliform viral (scbv) enhancer and its use in plant functional genomics
|
WO2012030738A2
(en)
|
2010-08-30 |
2012-03-08 |
Beckman Coulter, Inc. |
Complex phosphoprotein activation profiles
|
WO2012098260A1
(en)
|
2011-01-21 |
2012-07-26 |
Axiogenesis Ag |
A non-viral system for the generation of induced pluripotent stem (ips) cells
|
CN106248582B
(zh)
|
2011-01-21 |
2020-10-20 |
拉布拉多诊断有限责任公司 |
样品使用最大化的系统和方法
|
ES2666149T3
(es)
|
2011-03-25 |
2018-05-03 |
Monsanto Technology Llc |
Elementos reguladores de plantas y usos de los mismos
|
WO2012155071A1
(en)
|
2011-05-12 |
2012-11-15 |
Gilead Biologics, Inc. |
Methods of identifying lysyl oxidase - like - 2 (loxl2) binding partners
|
KR102080055B1
(ko)
|
2011-05-13 |
2020-02-24 |
몬산토 테크놀로지 엘엘씨 |
식물 조절 요소 및 그의 용도
|
US9574002B2
(en)
|
2011-06-06 |
2017-02-21 |
Amgen Inc. |
Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
|
US20140234330A1
(en)
|
2011-07-22 |
2014-08-21 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
US9619627B2
(en)
|
2011-09-25 |
2017-04-11 |
Theranos, Inc. |
Systems and methods for collecting and transmitting assay results
|
US20140170735A1
(en)
|
2011-09-25 |
2014-06-19 |
Elizabeth A. Holmes |
Systems and methods for multi-analysis
|
US9664702B2
(en)
|
2011-09-25 |
2017-05-30 |
Theranos, Inc. |
Fluid handling apparatus and configurations
|
US8475739B2
(en)
|
2011-09-25 |
2013-07-02 |
Theranos, Inc. |
Systems and methods for fluid handling
|
US8435738B2
(en)
|
2011-09-25 |
2013-05-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US9632102B2
(en)
|
2011-09-25 |
2017-04-25 |
Theranos, Inc. |
Systems and methods for multi-purpose analysis
|
US9268915B2
(en)
|
2011-09-25 |
2016-02-23 |
Theranos, Inc. |
Systems and methods for diagnosis or treatment
|
US8840838B2
(en)
|
2011-09-25 |
2014-09-23 |
Theranos, Inc. |
Centrifuge configurations
|
MX353958B
(es)
|
2011-09-22 |
2018-02-07 |
Amgen Inc |
Proteinas de union al antigeno cd27l.
|
US10012664B2
(en)
|
2011-09-25 |
2018-07-03 |
Theranos Ip Company, Llc |
Systems and methods for fluid and component handling
|
US9810704B2
(en)
|
2013-02-18 |
2017-11-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
CA2858572C
(en)
|
2011-12-08 |
2023-01-17 |
Amgen Inc. |
Human lcat antigen binding proteins and their use in therapy
|
US10077450B2
(en)
|
2012-02-29 |
2018-09-18 |
Dow Agrosciences Llc |
Sugarcane bacilliform viral (SCBV) enhancer and its use in plant functional genomics
|
US9663793B2
(en)
|
2012-04-20 |
2017-05-30 |
Monsanto Technology, Llc |
Plant regulatory elements and uses thereof
|
JO3623B1
(ar)
|
2012-05-18 |
2020-08-27 |
Amgen Inc |
البروتينات المرتبطة بمولد المستضاد st2
|
WO2013184950A2
(en)
|
2012-06-06 |
2013-12-12 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Kits for detecting and monitoring endocrine disrupting chemicals (edcs)
|
US9645151B2
(en)
|
2012-08-17 |
2017-05-09 |
California Institute Of Technology |
Targeting phosphofructokinase and its glycosylation form for cancer
|
US20150240253A1
(en)
|
2012-08-30 |
2015-08-27 |
E. I. Du Pont De Nemours And Company |
Long intergenic non-coding rnas in maize
|
TW201425336A
(zh)
|
2012-12-07 |
2014-07-01 |
Amgen Inc |
Bcma抗原結合蛋白質
|
JO3519B1
(ar)
|
2013-01-25 |
2020-07-05 |
Amgen Inc |
تركيبات أجسام مضادة لأجل cdh19 و cd3
|
ES2728936T3
(es)
|
2013-01-25 |
2019-10-29 |
Amgen Inc |
Anticuerpos dirigidos contra CDH19 para melanoma
|
US20140271629A1
(en)
|
2013-03-14 |
2014-09-18 |
Amgen Inc. |
Chrdl-1 antigen binding proteins and methods of treatment
|
US9850297B2
(en)
|
2013-03-15 |
2017-12-26 |
Amgen Inc. |
Secreted frizzle-related protein 5 (SFRP5) binding proteins
|
AR095596A1
(es)
|
2013-03-15 |
2015-10-28 |
Amgen Res (Munich) Gmbh |
Moléculas de unión de cadena única comprendiendo n-terminal abp
|
AP2015008732A0
(en)
|
2013-03-15 |
2015-09-30 |
Amgen Inc |
Human pac1 antibodies
|
US9505849B2
(en)
|
2013-03-15 |
2016-11-29 |
Amgen Research (Munich) Gmbh |
Antibody constructs for influenza M2 and CD3
|
EA201592285A1
(ru)
|
2013-05-30 |
2016-05-31 |
Байоджен Ма Инк. |
Антигенсвязывающие белки к рецептору онкостатина м
|
US10227370B2
(en)
|
2013-08-02 |
2019-03-12 |
California Institute Of Technology |
Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity
|
US9770461B2
(en)
|
2013-08-02 |
2017-09-26 |
California Institute Of Technology |
Tailored glycopolymers as anticoagulant heparin mimetics
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
AR097648A1
(es)
|
2013-09-13 |
2016-04-06 |
Amgen Inc |
Combinación de factores epigenéticos y compuestos biespecíficos que tienen como diana cd33 y cd3 en el tratamiento de leucemia mieloide
|
US9701743B2
(en)
|
2014-02-20 |
2017-07-11 |
Allergan, Inc. |
Complement component C5 antibodies
|
JP6643244B2
(ja)
|
2014-02-27 |
2020-02-12 |
アラーガン、インコーポレイテッドAllergan,Incorporated |
補体因子Bb抗体
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
WO2016007886A1
(en)
|
2014-07-11 |
2016-01-14 |
Northwestern University |
Yeast-based biosensor
|
WO2016016415A1
(en)
|
2014-07-31 |
2016-02-04 |
Amgen Research (Munich) Gmbh |
Bispecific single chain antibody construct with enhanced tissue distribution
|
JP6749312B2
(ja)
|
2014-07-31 |
2020-09-02 |
アムゲン リサーチ (ミュンヘン) ゲーエムベーハーAMGEN Research(Munich)GmbH |
最適化された種間特異的二重特異性単鎖抗体コンストラクト
|
AR101669A1
(es)
|
2014-07-31 |
2017-01-04 |
Amgen Res (Munich) Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
DE102014012130B3
(de)
|
2014-08-13 |
2015-03-05 |
Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung |
Nachweisverfahren unter Verwendung von rekombinanten lebenden Zellen zum Nachweis von xenobiotischen Stoffen sowie Anordnung und Testkit zur Durchführung des Nachweisverfahrens
|
WO2016040767A2
(en)
|
2014-09-12 |
2016-03-17 |
Amgen Inc. |
Chrdl-1 epitopes and antibodies
|
US11543411B2
(en)
|
2014-12-05 |
2023-01-03 |
Prelude Corporation |
DCIS recurrence and invasive breast cancer
|
SG11201705986QA
(en)
|
2015-01-29 |
2017-08-30 |
Technophage Investigação E Desenvolvimento Em Biotecnologia Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
MX2017010051A
(es)
|
2015-02-04 |
2018-07-06 |
Monsanto Technology Llc |
Métodos para transformación de plástidos.
|
EP3274462A4
(de)
|
2015-03-26 |
2018-12-26 |
The Texas A&M University System |
Umwandlung von lignin in biokunststoffe und lipidbrennstoffe
|
EP4276116A3
(de)
|
2015-04-17 |
2024-01-17 |
Amgen Research (Munich) GmbH |
Bispezifische antikörperkonstrukte für cdh3 und cd3
|
WO2016189118A1
(en)
|
2015-05-28 |
2016-12-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of prognosis and treatment of patients suffering from acute myeloid leukemia
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究(慕尼黑)公司 |
Cd70及cd3抗體構築體
|
TWI793062B
(zh)
|
2015-07-31 |
2023-02-21 |
德商安美基研究(慕尼黑)公司 |
Dll3及cd3抗體構築體
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
TWI829617B
(zh)
|
2015-07-31 |
2024-01-21 |
德商安美基研究(慕尼黑)公司 |
Flt3及cd3抗體構築體
|
TWI796283B
(zh)
|
2015-07-31 |
2023-03-21 |
德商安美基研究(慕尼黑)公司 |
Msln及cd3抗體構築體
|
PE20181327A1
(es)
|
2015-12-23 |
2018-08-20 |
Amgen Inc |
Metodo para tratar o mejorar trastornos metabolicos con proteinas de union para el receptor peptidico inhibidor gastrico (gipr) en combinacion con agonistas de glp-1
|
JOP20170017B1
(ar)
|
2016-01-25 |
2021-08-17 |
Amgen Res Munich Gmbh |
تركيب صيدلي يتضمن تركيبات جسم مضاد ثنائي الاختصاص
|
KR20180103084A
(ko)
|
2016-02-03 |
2018-09-18 |
암젠 리서치 (뮌헨) 게엠베하 |
Bcma 및 cd3 이중특이성 t 세포 맞물림 항체 작제물
|
EP3411404B1
(de)
|
2016-02-03 |
2022-11-09 |
Amgen Research (Munich) GmbH |
Psma- und cd3-bispezifische t-zellaktivierende antikörperkonstrukte
|
EA039859B1
(ru)
|
2016-02-03 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
JOP20170091B1
(ar)
|
2016-04-19 |
2021-08-17 |
Amgen Res Munich Gmbh |
إعطاء تركيبة ثنائية النوعية ترتبط بـ cd33 وcd3 للاستخدام في طريقة لعلاج اللوكيميا النخاعية
|
CA3029178C
(en)
|
2016-06-30 |
2022-07-19 |
Biois Co.,Ltd |
Double-stranded nucleic acid signal probe and method for detecting target molecule using same
|
EP3485020A1
(de)
|
2016-07-18 |
2019-05-22 |
University of Bremen |
Verfahren zur erzeugung von polyploiden pflanzen
|
CA3043515A1
(en)
|
2016-11-16 |
2018-05-24 |
Ablynx Nv |
T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta
|
JOP20190177A1
(ar)
|
2017-01-17 |
2019-07-16 |
Amgen Inc |
طريقة لعلاج أو تحسين اضطرابات أيضية باستخدام مساعدات مستقبل glp-1 مقترنة بمناهضات لمستقبل ببتيد مثبط معوي (gipr)
|
JOP20190189A1
(ar)
|
2017-02-02 |
2019-08-01 |
Amgen Res Munich Gmbh |
تركيبة صيدلانية ذات درجة حموضة منخفضة تتضمن بنيات جسم مضاد يستهدف الخلية t
|
WO2018151868A2
(en)
|
2017-02-16 |
2018-08-23 |
Sonnet Bio Therapeutics |
Albumin binding domain fusion proteins
|
WO2018204907A1
(en)
|
2017-05-05 |
2018-11-08 |
Amgen Inc. |
Pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration
|
JOP20190259A1
(ar)
|
2017-05-31 |
2019-10-31 |
Amgen Inc |
بروتينات ربط مولد ضد مضادة لـ jagged1
|
AR111842A1
(es)
|
2017-06-02 |
2019-08-21 |
Amgen Inc |
Antagonistas de péptido pac1
|
BR112019024410A2
(pt)
|
2017-06-20 |
2020-07-14 |
Amgen Inc. |
método de tratamento ou melhoria de disfunções metabólicas usando proteínas de ligação para receptor do peptídeo inibidor gástrico (gipr) em combinação com agonistas de glp 1
|
MX2020001327A
(es)
|
2017-08-04 |
2020-03-20 |
Amgen Inc |
Metodo de conjugacion de cys-acm.
|
EP3724229A1
(de)
|
2017-12-11 |
2020-10-21 |
Amgen Inc. |
Kontinuierliches herstellungsverfahren für bispezifische antikörperprodukte
|
TW201940518A
(zh)
|
2017-12-29 |
2019-10-16 |
美商安進公司 |
針對muc17和cd3之雙特異性抗體構建體
|
WO2019139616A1
(en)
|
2018-01-12 |
2019-07-18 |
The Texas A&M University System |
Increasing plant bioproduct yield
|
EP3758755A1
(de)
|
2018-02-26 |
2021-01-06 |
Ablynx N.V. |
Verbesserte, für peptidlinker kodierende nukleotidsequenzen
|
JP2021532140A
(ja)
|
2018-07-30 |
2021-11-25 |
アムジェン リサーチ (ミュニック) ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cd33及びcd3に結合する二重特異性抗体コンストラクトの長期投与
|
MA53330A
(fr)
|
2018-08-03 |
2021-06-09 |
Amgen Inc |
Constructions d'anticorps pour cldn18.2 et cd3
|
WO2020056338A1
(en)
|
2018-09-14 |
2020-03-19 |
Prelude Corporation |
Method of selection for treatment of subjects at risk of invasive breast cancer
|
WO2020069303A1
(en)
|
2018-09-28 |
2020-04-02 |
Amgen Inc. |
Antibodies against soluble bcma
|
JP2022512636A
(ja)
|
2018-10-11 |
2022-02-07 |
アムジエン・インコーポレーテツド |
二重特異性抗体コンストラクトの下流プロセシング
|
EP3877413A1
(de)
|
2018-11-06 |
2021-09-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren und pharmazeutische zusammensetzungen zur behandlung von akuter myeloischer leukämie durch vernichtung von leukämischen stammzellen
|
US11542333B2
(en)
|
2019-01-03 |
2023-01-03 |
Invetx, Inc. |
Compositions for increasing half-life of a therapeutic agent in canines and methods of use
|
TW202045711A
(zh)
|
2019-06-13 |
2020-12-16 |
美商安進公司 |
生物製品製造中基於生物量之自動灌注控制
|
MX2022002981A
(es)
|
2019-09-10 |
2022-04-06 |
Amgen Inc |
Metodo de purificacion para polipeptidos de union a antigeno biespecificos con capacidad de union dinamica de captura de proteina l mejorada.
|
CA3156683A1
(en)
|
2019-11-13 |
2021-05-20 |
Amgen Inc. |
METHOD FOR REDUCING AGGREGATE FORMATION IN DOWNSTREAM PROCESSING OF BI-SPECIFIC ANTIGEN-BINDING MOLECULES
|
WO2021150824A1
(en)
|
2020-01-22 |
2021-07-29 |
Amgen Research (Munich) Gmbh |
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
|
KR20220155338A
(ko)
|
2020-03-19 |
2022-11-22 |
암젠 인크 |
뮤신 17에 대한 항체 및 이의 용도
|
CN115867572A
(zh)
|
2020-05-11 |
2023-03-28 |
因外泰克斯公司 |
用于增加治疗剂在犬中的半衰期的组合物和使用方法
|
MX2022014636A
(es)
|
2020-05-19 |
2023-02-23 |
Amgen Inc |
Construcciones de unión a mageb2.
|
JP2023527972A
(ja)
|
2020-05-29 |
2023-07-03 |
アムジエン・インコーポレーテツド |
Cd33及びcd3に結合する二重特異性コンストラクトの有害作用軽減投与
|
WO2022008488A1
(en)
|
2020-07-06 |
2022-01-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of slamf1 as a biomarker in colorectal cancer
|
CN116096741A
(zh)
|
2020-07-10 |
2023-05-09 |
因外泰克斯公司 |
用于延长治疗剂在猫科动物中的半衰期的组合物和使用方法
|
WO2022013256A1
(en)
|
2020-07-15 |
2022-01-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of cd160 as a biomarker in acute myeloid leukemia
|
BR112023008670A2
(pt)
|
2020-11-06 |
2024-02-06 |
Amgen Inc |
Construtos polipeptídicos ligados à cd3
|
AU2021374839A1
(en)
|
2020-11-06 |
2023-06-08 |
Amgen Inc. |
Multitargeting bispecific antigen-binding molecules of increased selectivity
|
JP2023547662A
(ja)
|
2020-11-06 |
2023-11-13 |
アムジェン リサーチ (ミュニック) ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cldn6及びcd3に選択的に結合するポリペプチド構築物
|
WO2022096704A1
(en)
|
2020-11-06 |
2022-05-12 |
Amgen Inc. |
Antigen binding domain with reduced clipping rate
|
US20220236282A1
(en)
|
2021-01-20 |
2022-07-28 |
Nautilus Biotechnology, Inc. |
Systems and methods for biomolecule quantitation
|
AR125290A1
(es)
|
2021-04-02 |
2023-07-05 |
Amgen Inc |
Construcciones de unión a mageb2
|
EP4334358A1
(de)
|
2021-05-06 |
2024-03-13 |
Amgen Research (Munich) GmbH |
Cd20 und cd22 zielende antigenbindende moleküle zur verwendung bei proliferativen erkrankungen
|
US20230086871A1
(en)
|
2021-09-17 |
2023-03-23 |
University Of Freiburg |
Proteins for regulation of symbiotic infection and associated regulatory elements
|
US20230143932A1
(en)
|
2021-09-20 |
2023-05-11 |
University Of Freiburg |
Pin6 proteins for the formation of nodule-like structures
|
WO2023218027A1
(en)
|
2022-05-12 |
2023-11-16 |
Amgen Research (Munich) Gmbh |
Multichain multitargeting bispecific antigen-binding molecules of increased selectivity
|
US20240011044A1
(en)
|
2022-07-05 |
2024-01-11 |
University Of Freiburg |
Plant regulatory elements and uses thereof
|
WO2024052856A1
(en)
|
2022-09-09 |
2024-03-14 |
Friedrich Alexander Universität Erlangen-Nürnberg |
Plant regulatory elements and uses thereof
|
WO2024059675A2
(en)
|
2022-09-14 |
2024-03-21 |
Amgen Inc. |
Bispecific molecule stabilizing composition
|